nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ABIA: maintaining interest in HIV in Brazil
|
Daniels, Joe Parkin |
|
2019 |
|
10 |
p. e652 |
artikel |
2 |
Access to opioid agonist therapy in Russia: time for reform
|
Zelenev, Alexei |
|
2018 |
|
10 |
p. e542-e543 |
artikel |
3 |
Acción Solidaria: propping up HIV treatment in Venezuela
|
Daniels, Joe Parkin |
|
2018 |
|
10 |
p. e549 |
artikel |
4 |
Adolescent retention in HIV care within differentiated service-delivery models in sub-Saharan Africa
|
Maskew, Mhairi |
|
|
|
10 |
p. e726-e734 |
artikel |
5 |
Advancing bnAb combinations for HIV prevention
|
Gruell, Henning |
|
|
|
10 |
p. e625-e626 |
artikel |
6 |
Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial
|
Velloza, Jennifer |
|
|
|
10 |
p. e680-e689 |
artikel |
7 |
17 alpha-hydroxyprogesterone caproate, HIV, and preterm birth
|
Ntozini, Robert |
|
|
|
10 |
p. e600-e601 |
artikel |
8 |
A map to a better tomorrow
|
De Ambrogi, Marco |
|
2018 |
|
10 |
p. e551 |
artikel |
9 |
Anti-inflammatory therapy in well controlled HIV infection
|
Tarr, Philip E |
|
2018 |
|
10 |
p. e538-e539 |
artikel |
10 |
Anti-LGBT laws continue to hinder the HIV response
|
The Lancet HIV, |
|
|
|
10 |
p. e667 |
artikel |
11 |
Antiretroviral switch studies do matter
|
Daar, Eric S |
|
2018 |
|
10 |
p. e546 |
artikel |
12 |
Art and activism in New York
|
Martin, Colin |
|
2019 |
|
10 |
p. e653-e654 |
artikel |
13 |
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
|
Avihingsanon, Anchalee |
|
|
|
10 |
p. e640-e652 |
artikel |
14 |
BMS-663068, a safe and effective HIV-1 attachment inhibitor
|
Ballana, Ester |
|
2015 |
|
10 |
p. e404-e405 nvt p. |
artikel |
15 |
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial
|
Maggiolo, Franco |
|
2019 |
|
10 |
p. e655-e666 |
artikel |
16 |
Bringing history to life: Los Angeles' response to HIV/AIDS
|
Burki, Talha |
|
|
|
10 |
p. e638 |
artikel |
17 |
Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study
|
Ruffieux, Yann |
|
|
|
10 |
p. e614-e622 |
artikel |
18 |
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis
|
Ford, Nathan |
|
2015 |
|
10 |
p. e438-e444 nvt p. |
artikel |
19 |
Changing landscapes for HIV in Malaysia
|
Barmania, Sima |
|
|
|
10 |
p. e675-e676 |
artikel |
20 |
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use
|
Mbuagbaw, Lawrence |
|
|
|
10 |
p. e684-e689 |
artikel |
21 |
Cities getting to 90-90-90 and beyond
|
The Lancet HIV, |
|
2019 |
|
10 |
p. e639 |
artikel |
22 |
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
|
Leth, Steffen |
|
2016 |
|
10 |
p. e463-e472 nvt p. |
artikel |
23 |
Community-wide HIV testing, linkage case management, and defaulter tracing in Bukoba, Tanzania: pre-intervention and post-intervention, population-based survey evaluation
|
Steiner, Claire |
|
|
|
10 |
p. e699-e710 |
artikel |
24 |
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
|
Kanters, Steve |
|
2017 |
|
10 |
p. e433-e441 |
artikel |
25 |
Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countries
|
Galárraga, Omar |
|
2019 |
|
10 |
p. e705-e714 |
artikel |
26 |
Corrections
|
|
|
2015 |
|
10 |
p. e416- 1 p. |
artikel |
27 |
Corrections
|
|
|
2015 |
|
10 |
p. e416- 1 p. |
artikel |
28 |
Corrections
|
|
|
2016 |
|
10 |
p. e460- 1 p. |
artikel |
29 |
Correction to Lancet HIV 2018; DOI:10.1016/S2352-3018(18)30092-4
|
|
|
2018 |
|
10 |
p. e545 |
artikel |
30 |
Correction to Lancet HIV 2018; 5: e488–97
|
|
|
2018 |
|
10 |
p. e545 |
artikel |
31 |
Correction to Lancet HIV 2018; 5: e438–47
|
|
|
2018 |
|
10 |
p. e545 |
artikel |
32 |
Cost-effectiveness of early identification of HIV infection
|
Nichols, Brooke E |
|
2017 |
|
10 |
p. e431-e432 |
artikel |
33 |
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
|
Baggaley, Rebecca F |
|
2017 |
|
10 |
p. e465-e474 |
artikel |
34 |
Curbing HIV incidence in people who inject drugs
|
Malyuta, Ruslan |
|
2016 |
|
10 |
p. e453-e454 nvt p. |
artikel |
35 |
Data-driven HIV programming to maximise health benefits
|
Barnabas, Ruanne V |
|
|
|
10 |
p. e662-e663 |
artikel |
36 |
Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study
|
Krakower, Douglas S |
|
2019 |
|
10 |
p. e696-e704 |
artikel |
37 |
Differences in healthy longevity by HIV status and viral load among older South African adults: an observational cohort modelling study
|
Payne, Collin F |
|
|
|
10 |
p. e709-e716 |
artikel |
38 |
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
|
Calmy, Alexandra |
|
|
|
10 |
p. e677-e687 |
artikel |
39 |
Dolutegravir dosing with rifampicin
|
Cattaneo, Dario |
|
|
|
10 |
p. e635-e636 |
artikel |
40 |
Dolutegravir dosing with rifampicin – Authors' reply
|
Maartens, Gary |
|
|
|
10 |
p. e636 |
artikel |
41 |
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial
|
Venter, Willem D F |
|
|
|
10 |
p. e666-e676 |
artikel |
42 |
Drug-level feedback counselling: modest support to PrEP adherence
|
Hensen, Bernadette |
|
|
|
10 |
p. e668-e669 |
artikel |
43 |
Drug supply crisis in Venezuela
|
Daniels, Joe Parkin |
|
2018 |
|
10 |
p. e547-e548 |
artikel |
44 |
Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: a modelling study
|
Gonsalves, Gregg S |
|
2018 |
|
10 |
p. e569-e577 |
artikel |
45 |
Effect of a conditional cash transfer programme on AIDS incidence, hospitalisations, and mortality in Brazil: a longitudinal ecological study
|
de Sampaio Morais, Gabriel Alves |
|
|
|
10 |
p. e690-e699 |
artikel |
46 |
Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study
|
Ahamad, Keith |
|
2015 |
|
10 |
p. e445-e450 nvt p. |
artikel |
47 |
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study
|
Heffron, Renee |
|
2017 |
|
10 |
p. e449-e456 |
artikel |
48 |
Electronic health record tools to catalyse PrEP conversations
|
Ortblad, Katrina F |
|
2019 |
|
10 |
p. e644-e645 |
artikel |
49 |
Emergent HIV drug resistance in non-inferiority trials
|
Ripamonti, Diego |
|
|
|
10 |
p. e632-e634 |
artikel |
50 |
Engineered HIV antibody passes muster
|
Morris, Lynn |
|
2019 |
|
10 |
p. e641-e642 |
artikel |
51 |
Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings
|
Page, Kathleen R |
|
2018 |
|
10 |
p. e597-e604 |
artikel |
52 |
Enhancing efforts to address infections
|
Luz, Paula M |
|
2015 |
|
10 |
p. e406-e407 nvt p. |
artikel |
53 |
Estimating the impact of differentiated models for HIV care
|
Maskew, Mhairi |
|
|
|
10 |
p. e628-e630 |
artikel |
54 |
Expanding coverage of paediatric HIV testing
|
Chibwesha, Carla J |
|
2016 |
|
10 |
p. e451-e453 nvt p. |
artikel |
55 |
Families matter: differentiated service delivery for HIV
|
Srivastava, Meena |
|
2019 |
|
10 |
p. e646-e648 |
artikel |
56 |
From sharing needles to unprotected sex: a new wave of HIV infections in Iran?
|
Leylabadlo, Hamed Ebrahimzadeh |
|
2016 |
|
10 |
p. e461-e462 nvt p. |
artikel |
57 |
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019
|
|
|
|
|
10 |
p. e633-e651 |
artikel |
58 |
Harm reduction for smokers living with HIV
|
Shuter, Jonathan |
|
|
|
10 |
p. e652-e658 |
artikel |
59 |
Has UNAIDS left the Middle East and north Africa behind?
|
Rizk, Nesrine A |
|
|
|
10 |
p. e630-e632 |
artikel |
60 |
Health systems software factors and their effect on the integration of sexual and reproductive health and HIV services
|
Mayhew, Susannah H |
|
|
|
10 |
p. e711-e720 |
artikel |
61 |
Heightened epidemic in men who have sex with men in Brazil
|
Hogg, Robert S |
|
2016 |
|
10 |
p. e454-e455 nvt p. |
artikel |
62 |
HERO—providing support for those engaged in chemsex
|
Barmania, Sima |
|
|
|
10 |
p. e677 |
artikel |
63 |
HIV care continuum for key populations in Indonesia
|
Poudel, Krishna C |
|
2018 |
|
10 |
p. e539-e540 |
artikel |
64 |
HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men
|
Strong, Carol |
|
|
|
10 |
p. e717-e725 |
artikel |
65 |
HIV control in hyperendemic communities in east Africa
|
Zielinski-Gutierrez, Emily C |
|
2019 |
|
10 |
p. e643-e644 |
artikel |
66 |
HIV drug resistance in low-income and middle-income countries
|
Hamers, Raph L |
|
2018 |
|
10 |
p. e588-e596 |
artikel |
67 |
HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial
|
Booth, Robert E |
|
2016 |
|
10 |
p. e482-e489 nvt p. |
artikel |
68 |
HIV-related CNS infections: translating DREAMM into reality
|
Meya, David B |
|
|
|
10 |
p. e627-e628 |
artikel |
69 |
HIV stigma is a barrier to achieving 90-90-90 in India
|
Ekstrand, Maria L |
|
2018 |
|
10 |
p. e543-e545 |
artikel |
70 |
HIV testing and human rights: the right to the right test
|
Nkengasong, John N |
|
2016 |
|
10 |
p. e457-e458 nvt p. |
artikel |
71 |
HIV viral load messages should go viral in India
|
Isaakidis, Petros |
|
2015 |
|
10 |
p. e414-e415 nvt p. |
artikel |
72 |
HIV viral suppression is key to healthy longevity
|
Kiplagat, Jepchirchir |
|
|
|
10 |
p. e672-e673 |
artikel |
73 |
Homosexuality law reform is just a first step for India
|
The Lancet HIV, |
|
2018 |
|
10 |
p. e537 |
artikel |
74 |
Household survey of HIV incidence in Rwanda: a national observational cohort study
|
Nsanzimana, Sabin |
|
2017 |
|
10 |
p. e457-e464 |
artikel |
75 |
How will we get there? How will we know?
|
Eaton, Jeffrey W |
|
2017 |
|
10 |
p. e429-e430 |
artikel |
76 |
Impact of combination HIV interventions on HIV incidence in hyperendemic fishing communities in Uganda: a prospective cohort study
|
Kagaayi, Joseph |
|
2019 |
|
10 |
p. e680-e687 |
artikel |
77 |
Impact of differentiated service delivery models on 12-month retention in HIV treatment in Mozambique: an interrupted time-series analysis
|
Uetela, Dorlim A Moiana |
|
|
|
10 |
p. e674-e683 |
artikel |
78 |
Implementation guidance needed for PrEP risk-prediction tools
|
Calabrese, Sarah K |
|
2019 |
|
10 |
p. e649 |
artikel |
79 |
Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012–19): a longitudinal cohort study
|
van Santen, Daniela K |
|
|
|
10 |
p. e623-e632 |
artikel |
80 |
Improving services to tackle the syndemic of HIV and mental ill health
|
Nandi, Dhruva |
|
|
|
10 |
p. e674 |
artikel |
81 |
Incidence data do not count everyone
|
Negin, Joel |
|
|
|
10 |
p. e603 |
artikel |
82 |
Incidence data do not count everyone – Author's reply
|
Risher, Kathryn A |
|
|
|
10 |
p. e603 |
artikel |
83 |
Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies
|
Rutstein, Sarah E |
|
|
|
10 |
p. e721-e730 |
artikel |
84 |
INSTIs and weight gain in pregnancy
|
Bengtson, Angela M |
|
|
|
10 |
p. e663-e665 |
artikel |
85 |
Is it time to abandon single intervention cure trials?
|
Ananworanich, Jintanat |
|
2015 |
|
10 |
p. e410-e411 nvt p. |
artikel |
86 |
Is monotherapy maintenance the way forward?
|
Calmy, Alexandra |
|
2015 |
|
10 |
p. e402-e403 nvt p. |
artikel |
87 |
Is surgical preadmission an underused opportunity in HIV?
|
Acharya, Amish |
|
2016 |
|
10 |
p. e459-e460 nvt p. |
artikel |
88 |
It is time to act on ageing
|
The Lancet HIV, |
|
|
|
10 |
p. e599 |
artikel |
89 |
Legal impediments to prevention
|
Davis, Sara L M |
|
2016 |
|
10 |
p. e461- 1 p. |
artikel |
90 |
Liver disease in patients with HIV in sub-Saharan Africa
|
Cainelli, Francesca |
|
2015 |
|
10 |
p. e412-e413 nvt p. |
artikel |
91 |
Lung cancer in people living with HIV
|
Januszewski, Adam P |
|
|
|
10 |
p. e670-e672 |
artikel |
92 |
Lymphomas included in the AIDS case definition: an update 30 years later
|
Vaccher, Emanuela |
|
|
|
10 |
p. e635 |
artikel |
93 |
Mainline—confronting chemsex in the Netherlands
|
Kirby, Tony |
|
|
|
10 |
p. e678 |
artikel |
94 |
Methadone treatment in primary care
|
Wu, Zunyou |
|
2015 |
|
10 |
p. e408-e409 nvt p. |
artikel |
95 |
Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study
|
Coelho, Lara |
|
2016 |
|
10 |
p. e490-e498 nvt p. |
artikel |
96 |
Navigating the AIDS crisis with open hearts
|
Hayward, Peter |
|
|
|
10 |
p. e679 |
artikel |
97 |
Need for robust and inclusive public health ethics review of the monitoring of HIV phylogenetic clusters for HIV prevention
|
Gilbert, Mark |
|
2016 |
|
10 |
p. e461- 1 p. |
artikel |
98 |
No more Scott Counties
|
Beyrer, Chris |
|
2018 |
|
10 |
p. e541-e542 |
artikel |
99 |
Not your own story: the complexities of HIV disclosure in Ireland
|
Lucas, Cathy |
|
|
|
10 |
p. e639 |
artikel |
100 |
Optimising treatment in the test-and-treat strategy: what are we waiting for?
|
Phanuphak, Nittaya |
|
2019 |
|
10 |
p. e715-e722 |
artikel |
101 |
Paediatric HIV testing beyond the context of prevention of mother-to-child transmission: a systematic review and meta-analysis
|
Cohn, Jennifer |
|
2016 |
|
10 |
p. e473-e481 nvt p. |
artikel |
102 |
Paediatric HIV: the unfinished business
|
Penazzato, Martina |
|
2017 |
|
10 |
p. e425-e427 |
artikel |
103 |
Paying tribute to a generation devastated by HIV/AIDS
|
Burki, Talha |
|
|
|
10 |
p. e604 |
artikel |
104 |
Populism threatens Brazil's HIV/AIDS response
|
Daniels, Joe Parkin |
|
2019 |
|
10 |
p. e650-e651 |
artikel |
105 |
Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study
|
Cepeda, Javier A |
|
2018 |
|
10 |
p. e578-e587 |
artikel |
106 |
PrEP: why are we waiting?
|
The Lancet HIV, |
|
2015 |
|
10 |
p. e401- 1 p. |
artikel |
107 |
Prioritising the values of potential users to promote uptake of HIV pre-exposure prophylaxis
|
Traeger, Michael W |
|
|
|
10 |
p. e690-e692 |
artikel |
108 |
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial
|
Paton, Nicholas I |
|
2015 |
|
10 |
p. e417-e426 nvt p. |
artikel |
109 |
Public Health England's political end
|
The Lancet HIV, |
|
|
|
10 |
p. e661 |
artikel |
110 |
Putting people first in communication about HIV
|
The Lancet HIV, |
|
|
|
10 |
p. e623 |
artikel |
111 |
Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study
|
Mfinanga, Sayoki |
|
|
|
10 |
p. e663-e673 |
artikel |
112 |
Robust evidence of Bolsa Família Programme's benefits
|
Luz, Paula M |
|
|
|
10 |
p. e669-e670 |
artikel |
113 |
Russia's generalising HIV epidemic
|
The Lancet HIV, |
|
2016 |
|
10 |
p. e449- 1 p. |
artikel |
114 |
Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial
|
Lalezari, Jacob P |
|
2015 |
|
10 |
p. e427-e437 nvt p. |
artikel |
115 |
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
|
Baden, Lindsey R |
|
|
|
10 |
p. e688-e698 |
artikel |
116 |
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
|
Gaudinski, Martin R |
|
2019 |
|
10 |
p. e667-e679 |
artikel |
117 |
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial
|
Sobieszczyk, Magdalena E |
|
|
|
10 |
p. e653-e662 |
artikel |
118 |
Second-line antiretroviral therapy: so much to be done
|
Assefa, Yibeltal |
|
2017 |
|
10 |
p. e424-e425 |
artikel |
119 |
Switching antiretrovirals in older patients
|
Gianotti, Nicola |
|
2019 |
|
10 |
p. e640-e641 |
artikel |
120 |
Tackling cancer risk in adolescents and young adults with HIV
|
Davidson, Alan |
|
|
|
10 |
p. e601-e602 |
artikel |
121 |
The cascade of HIV care among key populations in Indonesia: a prospective cohort study
|
Januraga, Pande Putu |
|
2018 |
|
10 |
p. e560-e568 |
artikel |
122 |
The doctor's dilemma and vaccine therapy for HIV
|
Crowell, Trevor A |
|
2016 |
|
10 |
p. e450-e451 nvt p. |
artikel |
123 |
Transparency of participant incentives in HIV research
|
Brown, Brandon |
|
2016 |
|
10 |
p. e456-e457 nvt p. |
artikel |
124 |
Treating the parts other doctors cannot reach
|
Stirrups, Robert |
|
2018 |
|
10 |
p. e552 |
artikel |
125 |
Treatment of HIV and HBV coinfection
|
Bani-Sadr, Firouzé |
|
|
|
10 |
p. e624-e625 |
artikel |
126 |
Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study
|
Haas, Cameron B |
|
|
|
10 |
p. e700-e708 |
artikel |
127 |
UNAIDS departure leaves vacuum in leadership in MENA
|
Burki, Talha |
|
|
|
10 |
p. e637 |
artikel |
128 |
Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study
|
Marcus, Julia L |
|
2019 |
|
10 |
p. e688-e695 |
artikel |
129 |
Vaginal dysbiosis and pre-exposure prophylaxis efficacy
|
van de Wijgert, Janneke |
|
2017 |
|
10 |
p. e427-e429 |
artikel |
130 |
Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial
|
|
|
2018 |
|
10 |
p. e553-e559 |
artikel |
131 |
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
|
Price, Joan T |
|
|
|
10 |
p. e605-e613 |
artikel |
132 |
Would you like an HIV test?
|
The Lancet HIV, |
|
2017 |
|
10 |
p. e423 |
artikel |
133 |
Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study
|
Technau, Karl-Günter |
|
2017 |
|
10 |
p. e442-e448 |
artikel |
134 |
25 years later: the revival of Angels in America
|
Kirby, Tony |
|
2018 |
|
10 |
p. e550 |
artikel |